251 related articles for article (PubMed ID: 25476518)
21. Glioblastoma biomarkers from bench to bedside: advances and challenges.
Farias-Eisner G; Bank AM; Hwang BY; Appelboom G; Piazza MA; Bruce SS; Sander Connolly E
Br J Neurosurg; 2012 Apr; 26(2):189-94. PubMed ID: 22176646
[TBL] [Abstract][Full Text] [Related]
22. Neuroimaging: diagnosis and response assessment in glioblastoma.
Clarke JL; Chang SM
Cancer J; 2012; 18(1):26-31. PubMed ID: 22290254
[TBL] [Abstract][Full Text] [Related]
23. Advanced neuroimaging techniques in the management of glioblastoma multiforme.
Colonnese C; Romanelli P
Curr Radiopharm; 2012 Oct; 5(4):300-7. PubMed ID: 22642424
[TBL] [Abstract][Full Text] [Related]
24. Imaging genomic mapping in glioblastoma.
Zinn PO; Colen RR
Neurosurgery; 2013 Aug; 60 Suppl 1():126-30. PubMed ID: 23839364
[No Abstract] [Full Text] [Related]
25. Functional genomic analysis of glioblastoma multiforme through short interfering RNA screening: a paradigm for therapeutic development.
Thaker NG; Zhang F; McDonald PR; Shun TY; Lazo JS; Pollack IF
Neurosurg Focus; 2010 Jan; 28(1):E4. PubMed ID: 20043719
[TBL] [Abstract][Full Text] [Related]
26. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors.
Elshafeey N; Hassan I; Zinn PO; Colen RR
Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715
[TBL] [Abstract][Full Text] [Related]
27. Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.
Johanns TM; Dunn GP
Cancer J; 2017; 23(2):125-130. PubMed ID: 28410300
[TBL] [Abstract][Full Text] [Related]
28. New imaging techniques for more effective treatment in glioblastoma.
Fay MF; Martin JH; Rose S
Intern Med J; 2014 Jan; 44(1):5-6. PubMed ID: 24450518
[No Abstract] [Full Text] [Related]
29. Using genomics to guide treatment for glioblastoma.
Young JS; Prados MD; Butowski N
Pharmacogenomics; 2018 Oct; 19(15):1217-1229. PubMed ID: 30203716
[TBL] [Abstract][Full Text] [Related]
30. Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review.
Fathi Kazerooni A; Bakas S; Saligheh Rad H; Davatzikos C
J Magn Reson Imaging; 2020 Jul; 52(1):54-69. PubMed ID: 31456318
[TBL] [Abstract][Full Text] [Related]
31. Small extracellular vesicles as tumor biomarkers for glioblastoma.
Mahmoudi K; Ezrin A; Hadjipanayis C
Mol Aspects Med; 2015 Nov; 45():97-102. PubMed ID: 26118341
[TBL] [Abstract][Full Text] [Related]
32. Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study.
Qian X; Tan H; Zhang J; Liu K; Yang T; Wang M; Debinskie W; Zhao W; Chan MD; Zhou X
Oncotarget; 2016 Aug; 7(34):55377-55394. PubMed ID: 27421136
[TBL] [Abstract][Full Text] [Related]
33. Glioblastoma: molecular analysis and clinical implications.
Huse JT; Holland E; DeAngelis LM
Annu Rev Med; 2013; 64():59-70. PubMed ID: 23043492
[TBL] [Abstract][Full Text] [Related]
34. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
[TBL] [Abstract][Full Text] [Related]
35. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
36. Visualizing molecular profiles of glioblastoma with GBM-BioDP.
Celiku O; Johnson S; Zhao S; Camphausen K; Shankavaram U
PLoS One; 2014; 9(7):e101239. PubMed ID: 25010047
[TBL] [Abstract][Full Text] [Related]
37. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.
Drabycz S; Roldán G; de Robles P; Adler D; McIntyre JB; Magliocco AM; Cairncross JG; Mitchell JR
Neuroimage; 2010 Jan; 49(2):1398-405. PubMed ID: 19796694
[TBL] [Abstract][Full Text] [Related]
38. Progressive adult primary glioblastoma in the medulla oblongata with an unmethylated MGMT promoter and without an IDH mutation.
Yoshikawa A; Nakada M; Watanabe T; Hayashi Y; Sabit H; Kato Y; Suzuki S; Ooi A; Sato H; Hamada J
Brain Tumor Pathol; 2013 Jul; 30(3):175-9. PubMed ID: 23053494
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.
Verduin M; Compter I; Steijvers D; Postma AA; Eekers DBP; Anten MM; Ackermans L; Ter Laan M; Leijenaar RTH; van de Weijer T; Tjan-Heijnen VCG; Hoeben A; Vooijs M
Dis Markers; 2018; 2018():2908609. PubMed ID: 29581794
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
